Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Lipkowitz

Showing results (1-10 of 102) with videos related to

Pageof 11
Sort By:
JAMA|August 13, 2009
Pümpfrage redivivusBrandon Stone, Stanley Lipkowitz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
To Treat or Not to Treat: The Use of Hormone Replacement Therapy in Patients With Ovarian CancerStanley Lipkowitz, Elise C Kohn
Nature Reviews. Cancer|August 25, 2011
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisStanley Lipkowitz, Allan M Weissman
Science Signaling|February 18, 2016
ONC201: Stressing tumors to deathYoshimi Endo Greer, Stanley Lipkowitz
Cancer Biology & Therapy|January 17, 2007
PPARgamma agonists follow an unknown TRAIL in lung cancerStanley Lipkowitz, Phillip A Dennis
Oncoscience|April 11, 2015
TIC10/ONC201: a bend in the road to clinical developmentYoshimi Endo Greer, Stanley Lipkowitz
Advances in Cancer Research|October 27, 2009
The TRAIL to targeted therapy of breast cancerMonzur Rahman, Janet G Pumphrey, Stanley Lipkowitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2014
Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatmentMariya S Liyasova, Ke Ma, Stanley Lipkowitz
Cancer Treatment Reviews|March 21, 2016
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancerSherry X Yang, Eric Polley, Stanley Lipkowitz
Molecular Cancer Research : MCR|November 25, 2011
WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosisSireesha V Garimella, Andrea Rocca, Stanley Lipkowitz
Pageof 11

Showing results (1-10 of 102) with videos related to

Sort By:
Pageof 11
JAMA|August 13, 2009
Pümpfrage redivivusBrandon Stone, Stanley Lipkowitz
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 7, 2015
To Treat or Not to Treat: The Use of Hormone Replacement Therapy in Patients With Ovarian CancerStanley Lipkowitz, Elise C Kohn
Nature Reviews. Cancer|August 25, 2011
RINGs of good and evil: RING finger ubiquitin ligases at the crossroads of tumour suppression and oncogenesisStanley Lipkowitz, Allan M Weissman
Science Signaling|February 18, 2016
ONC201: Stressing tumors to deathYoshimi Endo Greer, Stanley Lipkowitz
Cancer Biology & Therapy|January 17, 2007
PPARgamma agonists follow an unknown TRAIL in lung cancerStanley Lipkowitz, Phillip A Dennis
Oncoscience|April 11, 2015
TIC10/ONC201: a bend in the road to clinical developmentYoshimi Endo Greer, Stanley Lipkowitz
Advances in Cancer Research|October 27, 2009
The TRAIL to targeted therapy of breast cancerMonzur Rahman, Janet G Pumphrey, Stanley Lipkowitz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2014
Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatmentMariya S Liyasova, Ke Ma, Stanley Lipkowitz
Cancer Treatment Reviews|March 21, 2016
New insights on PI3K/AKT pathway alterations and clinical outcomes in breast cancerSherry X Yang, Eric Polley, Stanley Lipkowitz
Molecular Cancer Research : MCR|November 25, 2011
WEE1 inhibition sensitizes basal breast cancer cells to TRAIL-induced apoptosisSireesha V Garimella, Andrea Rocca, Stanley Lipkowitz
Pageof 11